Shan Dan, Zhao Junzhao, Lu Xiaosheng, Zhang Huina, Lu Jieqiang, Shen Qi
Department of Gynecology and Obstetrics, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
PeerJ. 2024 Nov 26;12:e18635. doi: 10.7717/peerj.18635. eCollection 2024.
The basal luteinizing hormone (LH) and the prior LH to follicle-stimulating hormone (FSH) ratio (LH/FSH) in polycystic ovarian syndrome (PCOS) are generally higher than those in non-PCOS patients and the general population. The potential negative effects of elevated LH on human reproductive function are highly controversial, as are the effects of down-regulation of LH on reproductive function. The purpose of this study was to evaluate the effect of the basal LH/FSH ratio on the live birth rate of PCOS patients undergoing fertilization (IVF) cycles.
A retrospective analysis was conducted on 698 patients with polycystic ovary syndrome undergoing IVF treatments with a mild stimulation protocol ( = 95) and a gonadotropin-releasing hormone (GnRH) agonist protocol ( = 603). The basal LH/FSH ratio of 2 was used as the cut-off value for further subgroup analysis. The demographic properties, controlled ovarian hyperstimulation (COH) processes, and clinical pregnancy outcomes were compared between groups under each ovulation stimulation protocol.
The live birth rate for patients with a LH/FSH ratio ≥ 2 group (56.38%, = 149) was not statistically different from that of the ones with a ratio < 2 (53.74%, = 454) in the GnRH agonist protocol ( = 0.576). Correspondingly, the live birth rate for the LH/FSH ratio ≥ 2 group (43.48%, = 23) also showed no statistical difference from the ratio < 2 group (48.61%, = 72) in the mild stimulation protocol ( = 0.668). Additionally, LH/FSH ratios had no significant effect on the live birth rate after adjusting for confounders both in the GnRH agonist protocol (adjusted OR: 1.111; 95% CI [0.467-2.642], = 0.812) and in the mild stimulation protocol (adjusted OR: 4.057; 95% CI [0.431-38.195], = 0.221). Furthermore, there was no significant difference in the live birth rate between different ovulation stimulation protocols in PCOS patients with the LH/FSH ratio ≥ 2.
The live birth rate in IVF outcomes was not affected by an elevated basal LH/FSH ratio in patients with polycystic ovary syndrome. The choice of the GnRH agonist protocol or mild stimulation protocol for ovulation stimulation does not affect the final clinical outcomes either for PCOS patients with a basal LH/FSH ratio ≥ 2.
多囊卵巢综合征(PCOS)患者的基础促黄体生成素(LH)水平以及LH与促卵泡生成素(FSH)的比值(LH/FSH)通常高于非PCOS患者及普通人群。LH升高对人类生殖功能的潜在负面影响存在高度争议,LH下调对生殖功能的影响同样如此。本研究旨在评估基础LH/FSH比值对接受体外受精(IVF)周期的PCOS患者活产率的影响。
对698例接受轻度刺激方案(n = 95)和促性腺激素释放激素(GnRH)激动剂方案(n = 603)进行IVF治疗的多囊卵巢综合征患者进行回顾性分析。以LH/FSH比值为2作为进一步亚组分析的截断值。比较每种排卵刺激方案下各亚组间的人口统计学特征、控制性卵巢过度刺激(COH)过程及临床妊娠结局。
在GnRH激动剂方案中,LH/FSH比值≥2组患者的活产率(56.38%,n = 149)与比值<2组(53.74%,n = 454)相比,差异无统计学意义(P = 0.576)。相应地,在轻度刺激方案中,LH/FSH比值≥2组患者的活产率(43.48%,n = 23)与比值<2组(48.61%,n = 72)相比,也无统计学差异(P = 0.668)。此外,在GnRH激动剂方案(调整后的OR:1.111;95%CI[0.467 - 2.642],P = 0.812)和轻度刺激方案(调整后的OR:4.057;95%CI[0.431 - 38.195],P = 0.221)中,调整混杂因素后,LH/FSH比值对活产率均无显著影响。此外,LH/FSH比值≥2的PCOS患者在不同排卵刺激方案下的活产率也无显著差异。
多囊卵巢综合征患者基础LH/FSH比值升高并不影响IVF结局中的活产率。对于基础LH/FSH比值≥2的PCOS患者,选择GnRH激动剂方案或轻度刺激方案进行排卵刺激均不影响最终临床结局。